{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:54:55Z","timestamp":1784523295649,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K08944"],"award-info":[{"award-number":["16K08944"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Inokashira Hospital Grant for Psychiatry Research"},{"DOI":"10.13039\/100012835","name":"Toho University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.clinbiochem.2019.12.003","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T11:25:26Z","timestamp":1576236326000},"page":"48-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Alterations in methionine to homocysteine ratio in individuals with first-episode psychosis and those with at-risk mental state"],"prefix":"10.1016","volume":"77","author":[{"given":"Mayu","family":"Onozato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Uta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Magarida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Ichiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Tsujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Funatogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Tagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinbiochem.2019.12.003_b0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00204-018-2364-z","article-title":"Medicines associated with folate-homocysteine-methionine pathway disruption","volume":"93","author":"Vidmar","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.12.003_b0010","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.freeradbiomed.2012.02.033","article-title":"Methionine excess in diet induces acute lethal hepatitis in mice lacking cystathionine gamma-lyase, an animal model of cystathioninuria","volume":"52","author":"Yamada","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.12.003_b0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0300-2977(99)00132-1","article-title":"Hyperhomocysteinaemia as a cardiovascular risk factor: an update","volume":"56","author":"van der Griend","year":"2000","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arr.2019.02.006","article-title":"Hyperhomocysteinemia and risk of incident cognitive outcomes: an updated dose-response meta-analysis of prospective cohort studies","volume":"51","author":"Zhou","year":"2019","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.12.003_b0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12272-018-1016-4","article-title":"Causes of hyperhomocysteinemia and its pathological significance","volume":"41","author":"Kim","year":"2018","journal-title":"Arch. Pharmacol. Res."},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fpsyt.2019.00217","article-title":"Decreased serum oxytocin and increased homocysteine in first-episode schizophrenia patients","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0035","article-title":"Oxidative stress and inflammation in first-episode psychosis: a systematic review and meta-analysis","author":"Fraguas","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0040","article-title":"Homocysteine and psychiatric disorders","volume":"5","author":"Silva","year":"2019","journal-title":"JIEMS"},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.12.003_b0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.mp.4001746","article-title":"Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis","volume":"11","author":"Muntjewerff","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.12.003_b0050","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/schbul\/sbt154","article-title":"Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR c677t polymorphism in schizophrenia","volume":"40","author":"Nishi","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.12.003_b0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biopsych.2006.12.017","article-title":"Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia","volume":"63","author":"Roffman Joshua","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0060","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.19","article-title":"A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study","volume":"4","author":"Koike","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0065","article-title":"Federated multi-site longitudinal study of at-risk mental state for psychosis in Japan","volume":"343\u2013352","author":"Matsumoto","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eurpsy.2016.11.010","article-title":"Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders","volume":"42","author":"Fusar-Poli","year":"2017","journal-title":"Eur. Psychiatry"},{"issue":"7","key":"10.1016\/j.clinbiochem.2019.12.003_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101652","article-title":"Quantitative analyses of schizophrenia-associated metabolites in serum: serum d-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients","volume":"9","author":"Fukushima","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clinbiochem.2019.12.003_b0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archpsyc.60.6.572","article-title":"Decreased serum levels of d-serine in patients with schizophrenia \u2013 Evidence in support of the N-methyl-d-aspartate receptor hypofunction hypothesis of schizophrenia","volume":"60","author":"Hashimoto","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.schres.2017.09.021","article-title":"A systematic review of metabolite biomarkers of schizophrenia","volume":"195","author":"Davison","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0090","article-title":"Analyses of NMDA-receptor co-agonists in serum among individuals with at-risk mental state for psychosis","volume":"12","author":"Tagata","year":"2018","journal-title":"Early Interv. Psychia."},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0095","article-title":"Serum D- and L-lactate, pyruvate and glucose levels in individuals with at-risk mental state and correlations with clinical symptoms","author":"Onozato","year":"2019","journal-title":"Early Interv. Psychia."},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.12.003_b0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.12.003_b0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","article-title":"Comparison of beck depression inventories-IA and -II in psychiatric outpatients","volume":"67","author":"Beck","year":"1996","journal-title":"J. Pers. Assess."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.12.003_b0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0033-3182(95)71666-8","article-title":"Global assessment of functioning \u2013 a modified scale","volume":"36","author":"Hall","year":"1995","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.12.003_b0115","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-0623-5","article-title":"Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability","volume":"30","author":"Miller","year":"2004","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.12.003_b0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.euroneuro.2014.06.009","article-title":"Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale","volume":"25","author":"Keefe","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.12.003_b0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-1781(88)90038-8","article-title":"Reliability and validity of the positive and negative syndrome scale for schizophrenics","volume":"23","author":"Kay","year":"1988","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0130","series-title":"Structural Clinical Interview for DSM-IV Axis I Disorders (SCID-IV)","author":"First","year":"1997"},{"issue":"13","key":"10.1016\/j.clinbiochem.2019.12.003_b0135","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1039\/c3an00527e","article-title":"Fast and simultaneous analysis of biothiols by high-performance liquid chromatography with fluorescence detection under hydrophilic interaction chromatography conditions","volume":"138","author":"Isokawa","year":"2013","journal-title":"Analyst"},{"issue":"30","key":"10.1016\/j.clinbiochem.2019.12.003_b0140","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1007\/s00216-017-0682-2","article-title":"Liquid chromatography-mass spectrometry with triazole-bonded stationary phase for N-methyl-d-aspartate receptor-related amino acids: development and application in microdialysis studies","volume":"409","author":"Sakamoto","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0145","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jclinepi.2014.03.012","article-title":"False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies","volume":"67","author":"Glickman","year":"2014","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.12.003_b0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15407\/ubj88.05.107","article-title":"Measurement of methionine level with the LC-ESI-MS\/MS method in schizophrenic patients","volume":"88","author":"Kulaksizoglu","year":"2016","journal-title":"Ukr. Biochem. J."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2019.12.003_b0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.psychres.2009.01.013","article-title":"Reduced folic acid, vitamin B-12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism","volume":"175","author":"Kale","year":"2010","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.12.003_b0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biopsych.2018.12.018","article-title":"The vitamins in psychosis study: a randomized, double-blind, placebo-controlled trial of the effects of vitamins B-12, B-6, and folic acid on symptoms and neurocognition in first-episode psychosis","volume":"86","author":"Allott","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.clinbiochem.2019.12.003_b0165","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jocn.2013.12.030","article-title":"Cobalamin E defect, a rare inborn error of vitamin B12 metabolism: value of early diagnosis and treatment","volume":"21","author":"Kandula","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.clinbiochem.2019.12.003_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109679","article-title":"Evaluation of hyperhomocysteinemia prevalence and its influence on the selected cognitive functions in patients with schizophrenia","volume":"95","author":"Trzesniowska-Drukala","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019310203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019310203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:54:49Z","timestamp":1757865289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912019310203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":34,"alternative-id":["S0009912019310203"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.12.003","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in methionine to homocysteine ratio in individuals with first-episode psychosis and those with at-risk mental state","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}